EMA — authorised 28 October 2020
- Marketing authorisation holder: NOVARTIS EUROPHARM LIMITED
- Status: approved
🇪🇺 Selg1 in European Union
EMA authorised Selg1 on 28 October 2020
Marketing authorisation
Selg1 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Selg1 approved in European Union?
Yes. EMA authorised it on 28 October 2020.
Who is the marketing authorisation holder for Selg1 in European Union?
NOVARTIS EUROPHARM LIMITED holds the EU marketing authorisation.